Option Care Health (NASDAQ:OPCH) Rating Increased to Hold at Zacks Research

Option Care Health (NASDAQ:OPCH) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

Several other research firms have also recently commented on OPCH. The Goldman Sachs Group initiated coverage on Option Care Health in a research note on Monday, June 8th. They set a “neutral” rating and a $22.00 price target for the company. Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a research note on Wednesday, May 6th. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective for the company. in a research report on Friday, May 1st. Truist Financial set a $30.00 target price on shares of Option Care Health in a report on Friday, May 1st. Finally, Stephens set a $30.00 price target on shares of Option Care Health in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Stock Performance

NASDAQ OPCH opened at $21.57 on Monday. The firm has a market cap of $3.39 billion, a P/E ratio of 16.72, a P/E/G ratio of 1.19 and a beta of 0.65. Option Care Health has a 52-week low of $18.01 and a 52-week high of $36.80. The business’s 50-day moving average price is $21.39 and its 200 day moving average price is $28.06. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. During the same period last year, the firm earned $0.40 EPS. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts expect that Option Care Health will post 1.64 earnings per share for the current year.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average price of $21.41 per share, with a total value of $783,820.10. Following the completion of the acquisition, the director owned 450,000 shares in the company, valued at approximately $9,634,500. This represents a 8.86% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Timothy P. Sullivan bought 24,154 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was bought at an average cost of $20.69 per share, with a total value of $499,746.26. Following the completion of the acquisition, the director owned 73,383 shares of the company’s stock, valued at $1,518,294.27. This represents a 49.06% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 73,264 shares of company stock worth $1,548,316 over the last 90 days. Company insiders own 1.70% of the company’s stock.

Institutional Trading of Option Care Health

A number of institutional investors have recently bought and sold shares of OPCH. Durable Capital Partners LP grew its holdings in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after purchasing an additional 4,720,988 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in shares of Option Care Health by 12.1% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after buying an additional 752,058 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of Option Care Health by 6.2% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock worth $135,355,000 after buying an additional 247,118 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Option Care Health by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after buying an additional 36,208 shares in the last quarter. Finally, Southpoint Capital Advisors LP grew its stake in Option Care Health by 20.0% in the 1st quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock valued at $96,912,000 after acquiring an additional 600,000 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.